SCHEMBL7070904

SCHEMBL7070904

CCOC(Cc1ccc(OCc2cnc3ccc(OC)cc3c2OC)cc1)C(=O)O

nearest known ligand 0.57

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 20/20 0.57
PPARG P37231 15/20 0.52
PPARD Q03181 12/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7066794 0.95 PPARA (0.56) PPARAPPARGPPARD
SCHEMBL7067668 0.93 PPARA (0.53) PPARAPPARGPPARD
SCHEMBL7069893 0.93 PPARA (0.53) PPARAPPARGPPARD
SCHEMBL7067228 0.90 PPARA (0.51) PPARAPPARGPPARD
SCHEMBL7067409 0.90 PPARA (0.51) PPARAPPARGPPARD
SCHEMBL7066078 0.90 PPARA (0.56) PPARAPPARGPPARD
SCHEMBL7070111 0.89 PPARA (0.58) PPARAPPARGPPARD
SCHEMBL7070910 0.86 MAPT (0.42) PPARAPPARGPPARD
SCHEMBL7072676 0.85 PPARA (0.53) PPARAPPARGPPARD
SCHEMBL7066498 0.84 PPARA (0.43) PPARAPPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030212100-A1 Quinoline derivatives and medicinal use thereof MITSUI CHEMICALS, INC. (JP) 2003-11-13 US disclosed
EP-1266888-A1 QUINOLINE DERIVATIVES AND MEDICINAL USE THEREOF Mitsui Chemicals, Inc. (JP) 2002-12-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030212100-A1 Quinoline derivatives and medicinal use thereof PPARG, PPARD, PPARA PPARA 3/4885PPARG 1/4885PPARD 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.